(Q33405522)

English

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome (English)

1 reference

Europe PubMed Central

26 July 2017

author name string

M Le Quintrec

1

1 reference

Europe PubMed Central

26 July 2017

J Zuber

2

1 reference

Europe PubMed Central

26 July 2017

B Moulin

3

1 reference

Europe PubMed Central

26 July 2017

N Kamar

4

1 reference

Europe PubMed Central

26 July 2017

M Jablonski

5

1 reference

Europe PubMed Central

26 July 2017

A Lionet

6

1 reference

Europe PubMed Central

26 July 2017

V Chatelet

7

1 reference

Europe PubMed Central

26 July 2017

C Mousson

8

1 reference

Europe PubMed Central

26 July 2017

G Mourad

9

1 reference

Europe PubMed Central

26 July 2017

F Bridoux

10

1 reference

Europe PubMed Central

26 July 2017

E Cassuto

11

1 reference

Europe PubMed Central

26 July 2017

C Loirat

12

1 reference

Europe PubMed Central

26 July 2017

E Rondeau

13

1 reference

Europe PubMed Central

26 July 2017

M Delahousse

14

1 reference

Europe PubMed Central

26 July 2017

V Frémeaux-Bacchi

15

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

28 January 2013

1 reference

Europe PubMed Central

26 July 2017

American Journal of Transplantation

1 reference

Europe PubMed Central

26 July 2017

13

1 reference

Europe PubMed Central

26 July 2017

3

1 reference

Europe PubMed Central

26 July 2017

663-675

1 reference

Europe PubMed Central

26 July 2017

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

New insights into postrenal transplant hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Atypical hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Delayed graft function: risk factors and implications for renal allograft survival

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Cyclosporine and tacrolimus-associated thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

From humoral rejection to generalized thrombotic microangiopathy--role of acquired ADAMTS13 deficiency in a renal allograft recipient.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Alternative complement pathway assessment in patients with atypical HUS.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Thrombotic Microangiopathies

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Myocardial infarction is a complication of factor H-associated atypical HUS.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF).

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Liver-kidney transplantation to cure atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Plasmatherapy in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Thrombotic microangiopathy after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Recurrence of hemolytic uremic syndrome after renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Graft-derived complement as a mediator of transplant injury

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Thrombotic Microangiopathy After Kidney Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12077

21 January 2018

Identifiers

10.1111/AJT.12077

1 reference

Europe PubMed Central

26 July 2017

release_br55xweeyjaa7o5ir4d3p3if2i

1 reference

https://api.fatcat.wiki/v0/release/br55xweeyjaa7o5ir4d3p3if2i

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33405522&oldid=1958409930"